Somaxon Pharmaceuticals, Inc. Logo Image

Somaxon Pharmaceuticals, Inc.

Most Recent Annual Report

2014 Annual Report

Somaxon Pharmaceuticals, Inc.

Somaxon Pharmaceuticals, Inc. does not currently have any hardcopy reports available on AnnualReports.com. Click the button below to be notified when hardcopies become available.



Archived Annual Reports

  • Somaxon Pharmaceuticals, Inc.

About Somaxon Pharmaceuticals, Inc.

Somaxon Pharmaceuticals, Inc., a specialty pharmaceutical company, focuses on the in-licensing, development, and commercialization of proprietary branded products and late-stage product candidates for the treatment medical conditions in the central nervous system therapeutic area. Its product includes Silenor for the treatment of insomnia characterized by difficulty with sleep maintenance.

Ticker:
SOMX
Exchange:
NASDAQ (See More NASDAQ Companies)
Industry:
Drug Manufacturers - Other (See More Drug Manufacturers - Other Companies)
Sector:
Healthcare (See More Healthcare Companies)

Looking for Other Annual Reports?

Search by company name or ticker symbol